Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NAMS compared with PHAT: revenue, margins and what each company keeps, and the suppliers and customers both name
NAMS
NewAmsterdam Pharma Co N.V.
Change
Mkt cap
Revenue
Revenue
PHAT
Phathom Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
NAMS
NewAmsterdam Pharma Co N.V.
vs
PHAT
Phathom Pharmaceuticals, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
NAMS
NewAmsterdam Pharma Co N.V.
Change
18.90
▲
+0.05%
· post 18.80
Mkt cap
$2.3B
Revenue
$19M
Q3 FY26
Revenue
$23M
FY25
PHAT
Phathom Pharmaceuticals, Inc.
Change
5.23
▲
+2.87%
· post 5.23
Closed
Nov 6 '26
Mkt cap
$413.0M
Revenue
$85M
Q3 FY26
Revenue
$175M
FY25
vs
Compare
Closed
Nov 6 '26
NAMS
NewAmsterdam Pharma Co N.V.
vs
PHAT
Phathom Pharmaceuticals, Inc.
18.90
▲
+0.05%
post 18.80
Price
5.23
▲
+2.87%
post 5.23
$2.3B
Mkt cap
$413.0M
Q3 FY26
$19M
Revenue
$85M
Q3 FY26
FY25
$23M
Revenue
$175M
FY25
Change
Change
NAMS
18.90
▲
+0.05%
vs
PHAT
5.23
▲
+2.87%
Closed
Nov 6 '26
Co-movers
daily closes
Method
›
Moved together
NAMS
with
PHAT
No shared trading history for NAMS and PHAT.
Shared co-movers: not yet measured (NAMS).
NAMS, solid
PHAT, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes